 To estimate annualized total cost rates i.e. direct medical costs from hospitalizations, consultations, medications, and tests of adequately controlling a patient i.e. INR between 2-3 and TTR 60 diagnosed with non-valvular atrial fibrillation NVAF or venous thromboembolism VTE, and treated with vitamin K antagonists VKA in Spain. 